(Q39359674)

11 September 2017

0 references

Role of botulinum toxin type A in the prophylactic treatment of migraine headaches (English)

1 reference

11 September 2017

1 reference

1 reference

botulinum toxin type A

1 reference

Crystal N Chilson

1

1 reference

11 September 2017

Sherrill J Brown

series ordinal

2

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Annals of Pharmacotherapy

11 September 2017

published in

1 reference

11 September 2017

volume

39

1 reference

11 September 2017

issue

12

1 reference

11 September 2017

page(s)

2081-2085

1 reference

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

11 September 2017

cites work

1 reference

Pharmacologic management of acute attacks of migraine and prevention of migraine headache

21 January 2018

1 reference

The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers

21 January 2018

1 reference

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study

21 January 2018

1 reference

Use of botulinum toxins for chronic headaches: a focused review.

21 January 2018

1 reference

Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders

21 January 2018

1 reference

Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

A quantification of the placebo response in migraine prophylaxis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G239

1 reference

11 September 2017

1 reference